title: Functional genomic and serological analysis of the protective immune response resulting from vaccination of macaques with an NS1-truncated influenza virus.
abstract: We are still inadequately prepared for an influenza pandemic due to the lack of a vaccine effective for subtypes to which the majority of the human population has no prior immunity and which could be produced rapidly in sufficient quantities. There is therefore an urgent need to investigate novel vaccination approaches. Using a combination of genomic and traditional tools, this study compares the protective efficacy in macaques of an intrarespiratory live influenza virus vaccine produced by truncating NS1 in the human influenza A/Texas/36/91 (H1N1) virus with that of a conventional vaccine based on formalin-killed whole virus. After homologous challenge, animals in the live-vaccine group had greatly reduced viral replication and pathology in lungs and reduced upper respiratory inflammation. They also had lesser induction of innate immune pathways in lungs and of interferon-sensitive genes in bronchial epithelium. This postchallenge response contrasted with that shortly after vaccination, when more expression of interferon-sensitive genes was observed in bronchial cells from the live-vaccine group. This suggested induction of a strong innate immune response shortly after vaccination with the NS1-truncated virus, followed by greater maturity of the postchallenge immune response, as demonstrated with robust influenza virus-specific CD4+ T-cell proliferation, immunoglobulin G production, and transcriptional induction of T- and B-cell pathways in lung tissue. In conclusion, a single respiratory tract inoculation with an NS1-truncated influenza virus was effective in protecting nonhuman primates from homologous challenge. This protection was achieved in the absence of significant or long-lasting adverse effects and through induction of a robust adaptive immune response.
authors: Department of Comparative Medicine, University of Washington, Seattle, Washington 981951,USA. carole.baskin@asu.edu
authors: C R
authors: CR
authors: Baskin
authors: H
authors: H
authors: Bielefeldt-Ohmann
authors: A
authors: A
authors: García-Sastre
authors: T M
authors: TM
authors: Tumpey
authors: N
authors: N
authors: Van Hoeven
authors: V S
authors: VS
authors: Carter
authors: M J
authors: MJ
authors: Thomas
authors: S
authors: S
authors: Proll
authors: A
authors: A
authors: Solórzano
authors: R
authors: R
authors: Billharz
authors: J L
authors: JL
authors: Fornek
authors: S
authors: S
authors: Thomas
authors: C-H
authors: CH
authors: Chen
authors: E A
authors: EA
authors: Clark
authors: Kaja
authors: K
authors: Murali-Krishna
authors: M G
authors: MG
authors: Katze
mesh_terms: D000818:Animals; D001706:Biopsy; D001769:Blood / Q000821:virology; D001980:Bronchi / Q000473:pathology / Q000821:virology; D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism; D004848:Epithelium / Q000821:virology; D005260:Female; D015967:Gene Expression Regulation, Viral; D007107:Immune System / Q000821:virology*; D053118:Influenza A Virus, H1N1 Subtype / Q000378:metabolism; D008251:Macaca; D008297:Male; D009975:Orthomyxoviridae / Q000235:genetics* / Q000378:metabolism*; D014158:Transcription, Genetic; D017361:Viral Nonstructural Proteins / Q000737:chemistry* / Q000502:physiology
chemical_list: C085820:INS1 protein, influenza virus; D017361:Viral Nonstructural Proteins
references: J Virol. 2004 Dec;78(23):13037-45
references: 15542655
references: N Engl J Med. 2007 Feb 15;356(7):729-31
references: 17301305
references: J Gen Virol. 2005 Jan;86(Pt 1):185-95
references: 15604446
references: Appl Microbiol Biotechnol. 2005 May;67(3):299-305
references: 15660212
references: Vet Pathol. 2005 May;42(3):391-6
references: 15872392
references: J Virol. 2005 Jun;79(12):7535-43
references: 15919908
references: J Virol. 2005 Jul;79(13):8431-9
references: 15956587
references: Science. 2005 Aug 12;309(5737):996
references: 16099954
references: J Gen Virol. 2005 Oct;86(Pt 10):2817-21
references: 16186237
references: J Exp Med. 2005 Nov 21;202(10):1433-42
references: 16301748
references: Vaccine. 2006 Feb 20;24(8):1180-90
references: 16194586
references: J Immunol. 2006 Apr 1;176(7):4343-51
references: 16547272
references: Proc Natl Acad Sci U S A. 2006 May 2;103(18):7100-5
references: 16627618
references: Lancet. 2006 May 20;367(9523):1657-64
references: 16714186
references: Virology. 2006 May 25;349(1):13-21
references: 16466763
references: J Virol. 2006 Jul;80(13):6295-304
references: 16775317
references: J Am Assoc Lab Anim Sci. 2006 Jul;45(4):44-8
references: 16884179
references: Nat Rev Microbiol. 2006 Aug;4(8):565-6
references: 16888876
references: Lancet. 2006 Sep 16;368(9540):965-6
references: 16980092
references: Lancet. 2006 Sep 16;368(9540):991-7
references: 16980114
references: J Infect Dis. 2006 Oct 15;194(8):1032-9
references: 16991077
references: Nature. 2006 Oct 5;443(7111):578-81
references: 17006449
references: J Virol. 2006 Nov;80(21):10813-28
references: 16928763
references: Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):15987-91
references: 17043214
references: Biochem J. 2005 Jan 1;385(Pt 1):85-93
references: 15320871
references: Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4309-14
references: 10725408
references: J Virol. 2000 Sep;74(17):7989-96
references: 10933707
references: Mol Cell Biol. 2000 Sep;20(17):6259-68
references: 10938102
references: J Virol. 2000 Dec;74(24):11566-73
references: 11090154
references: Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2746-51
references: 11226311
references: Immunity. 2001 Apr;14(4):461-70
references: 11336691
references: J Virol. 2001 Jul;75(14):6687-91
references: 11413336
references: Curr Opin Immunol. 2002 Aug;14(4):432-6
references: 12088676
references: Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10736-41
references: 12149435
references: Int Rev Immunol. 2002 Jul-Oct;21(4-5):305-37
references: 12486817
references: Virology. 2003 May 10;309(2):181-9
references: 12758165
references: Avian Dis. 2003;47(3 Suppl):931-3
references: 14575089
references: Scand J Immunol. 2004 Jan;59(1):1-15
references: 14723616
references: Am J Pathol. 2004 Mar;164(3):1021-30
references: 14982855
references: Cytogenet Genome Res. 2004;105(1):11-7
references: 15218252
references: J Virol. 2004 Oct;78(19):10420-32
references: 15367608
references: Clin Immunol Immunopathol. 1991 Aug;60(2):153-70
references: 1649026
references: J Gen Virol. 1997 Apr;78 ( Pt 4):757-65
references: 9129647
references: J Infect Dis. 1997 Feb;175(2):352-63
references: 9203656
references: N Engl J Med. 1998 May 14;338(20):1405-12
references: 9580647
references: Virology. 1998 Dec 20;252(2):324-30
references: 9878611
references: Nat Med. 1999 Oct;5(10):1157-63
references: 10502819
references: J Virol. 2006 Nov;80(22):11009-18
references: 16943300
references: Science. 2006 Nov 10;314(5801):997-1001
references: 17038589
references: J Pediatr. 2006 Dec;149(6):737-8
references: 17137882
references: J Virol. 2007 Jan;81(2):514-24
references: 17079289
references: Nature. 2007 Jan 18;445(7125):319-23
references: 17230189